Literature DB >> 27696693

The silent overall burden of foot disease in a representative hospitalised population.

Peter A Lazzarini1,2,3,4, Sheree E Hurn1,2, Suzanne S Kuys3,5, Maarten C Kamp1, Vanessa Ng3, Courtney Thomas6, Scott Jen7, Jude Wills8, Ewan M Kinnear3, Michael C d'Emden1,9, Lloyd F Reed1,2.   

Abstract

The aims of this study were to investigate the point prevalence, and associated independent factors, for foot disease (ulcers, infections and ischaemia) in a representative hospitalised population. We included 733 (83%) of 883 eligible adult inpatients across five representative Australian hospitals on one day. We collected an extensive range of self-reported characteristics from participants. We examined all participants to clinically diagnose foot disease (ulcers, infections and ischaemia) and amputation procedures. Overall, 72 participants (9·8%) [95% confidence interval (CI):7·2-11·3%] had foot disease. Foot ulcers, in 49 participants (6·7%), were independently associated with peripheral neuropathy, peripheral arterial disease, previous foot ulcers, trauma and past surgeon treatment (P < 0·05). Foot infections, in 24 (3·3%), were independently associated with previous foot ulcers, trauma and past surgeon treatment (P < 0·01). Ischaemia, in 33 (4·5%), was independently associated with older age, smokers and past surgeon treatment (P < 0·01). Amputation procedures, in 14 (1·9%), were independently associated with foot infections (P < 0·01). We found that one in every ten inpatients had foot disease, and less than half of those had diabetes. After adjusting for diabetes, factors linked with foot disease were similar to those identified in diabetes-related literature. The overall inpatient foot disease burden is similar in size to well-known medical conditions and should receive similar attention.
© 2016 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Factors; Foot disease; Foot wounds; Inpatients; Prevalence

Mesh:

Year:  2016        PMID: 27696693      PMCID: PMC7949819          DOI: 10.1111/iwj.12683

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  22 in total

1.  Validation of the Infectious Diseases Society of America's diabetic foot infection classification system.

Authors:  Lawrence A Lavery; David G Armstrong; Douglas P Murdoch; Edgar J G Peters; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2007-01-17       Impact factor: 9.079

Review 2.  Lower extremity amputations--a review of global variability in incidence.

Authors:  P W Moxey; P Gogalniceanu; R J Hinchliffe; I M Loftus; K J Jones; M M Thompson; P J Holt
Journal:  Diabet Med       Date:  2011-10       Impact factor: 4.359

Review 3.  Risk stratification systems for diabetic foot ulcers: a systematic review.

Authors:  M Monteiro-Soares; E J Boyko; J Ribeiro; I Ribeiro; M Dinis-Ribeiro
Journal:  Diabetologia       Date:  2011-01-20       Impact factor: 10.122

4.  High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders.

Authors:  P Lacroix; V Aboyans; D Voronin; A Le Guyader; M Cautrès; M Laskar
Journal:  Int J Clin Pract       Date:  2007-11-19       Impact factor: 2.503

Review 5.  Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies.

Authors:  N C Schaper
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

6.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).

Authors:  Joseph L Mills; Michael S Conte; David G Armstrong; Frank B Pomposelli; Andres Schanzer; Anton N Sidawy; George Andros
Journal:  J Vasc Surg       Date:  2013-10-12       Impact factor: 4.268

7.  Reduced Incidence of Foot-Related Hospitalisation and Amputation amongst Persons with Diabetes in Queensland, Australia.

Authors:  Peter A Lazzarini; Sharon R O'Rourke; Anthony W Russell; Patrick H Derhy; Maarten C Kamp
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Direct inpatient burden caused by foot-related conditions: a multisite point-prevalence study.

Authors:  Peter A Lazzarini; Sheree E Hurn; Suzanne S Kuys; Maarten C Kamp; Vanessa Ng; Courtney Thomas; Scott Jen; Ewan M Kinnear; Michael C d'Emden; Lloyd Reed
Journal:  BMJ Open       Date:  2016-06-20       Impact factor: 2.692

9.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

10.  The Queensland high risk foot form (QHRFF) - is it a reliable and valid clinical research tool for foot disease?

Authors:  Peter A Lazzarini; Vanessa Ng; Ewan M Kinnear; Maarten C Kamp; Suzanne S Kuys; Cameron Hurst; Lloyd F Reed
Journal:  J Foot Ankle Res       Date:  2014-01-28       Impact factor: 2.303

View more
  13 in total

1.  Moderate-to-Vigorous-Intensity Physical Activity Observed in People With Diabetes-Related Foot Ulcers Over a One-Week Period.

Authors:  Maggie Lee; Jaap J van Netten; Helen Sheahan; Peter A Lazzarini
Journal:  J Diabetes Sci Technol       Date:  2019-05-29

2.  Measuring Plantar Tissue Stress in People With Diabetic Peripheral Neuropathy: A Critical Concept in Diabetic Foot Management.

Authors:  Peter A Lazzarini; Ryan T Crews; Jaap J van Netten; Sicco A Bus; Malindu E Fernando; Paul J Chadwick; Bijan Najafi
Journal:  J Diabetes Sci Technol       Date:  2019-04-29

3.  Australian guideline on prevention of foot ulceration: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Michelle R Kaminski; Jonathan Golledge; Joel W J Lasschuit; Karl-Heinz Schott; James Charles; Jane Cheney; Anita Raspovic
Journal:  J Foot Ankle Res       Date:  2022-07-06       Impact factor: 3.050

4.  Foot Complications in a Representative Australian Inpatient Population.

Authors:  Peter A Lazzarini; Sheree E Hurn; Suzanne S Kuys; Maarten C Kamp; Vanessa Ng; Courtney Thomas; Scott Jen; Jude Wills; Ewan M Kinnear; Michael C d'Emden; Lloyd F Reed
Journal:  J Diabetes Res       Date:  2017-10-15       Impact factor: 4.011

5.  Independent factors associated with wearing different types of outdoor footwear in a representative inpatient population: a cross-sectional study.

Authors:  Alex L Barwick; Jaap J van Netten; Lloyd F Reed; Peter A Lazzarini
Journal:  J Foot Ankle Res       Date:  2018-05-29       Impact factor: 2.303

6.  Factors associated with wearing inadequate outdoor footwear in populations at risk of foot ulceration: A cross-sectional study.

Authors:  Alex L Barwick; Sheree E Hurn; Jaap J van Netten; Lloyd F Reed; Peter A Lazzarini
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

7.  Factors associated with type of footwear worn inside the house: a cross-sectional study.

Authors:  Alex L Barwick; Jaap J van Netten; Sheree E Hurn; Lloyd F Reed; Peter A Lazzarini
Journal:  J Foot Ankle Res       Date:  2019-08-23       Impact factor: 2.303

Review 8.  Diabetes-related foot disease in Australia: a systematic review of the prevalence and incidence of risk factors, disease and amputation in Australian populations.

Authors:  Yuqi Zhang; Jaap J van Netten; Mendel Baba; Qinglu Cheng; Rosana Pacella; Steven M McPhail; Susanna Cramb; Peter A Lazzarini
Journal:  J Foot Ankle Res       Date:  2021-01-19       Impact factor: 2.303

9.  Incorporating foot assessment in the comprehensive geriatric assessment.

Authors:  Rebecca K Iseli; Gregory Duncan; Elton K Lee; Ellen Lewis; Andrea B Maier
Journal:  BMC Geriatr       Date:  2021-04-01       Impact factor: 3.921

10.  Diabetic Foot Australia guideline on footwear for people with diabetes.

Authors:  Jaap J van Netten; Peter A Lazzarini; David G Armstrong; Sicco A Bus; Robert Fitridge; Keith Harding; Ewan Kinnear; Matthew Malone; Hylton B Menz; Byron M Perrin; Klaas Postema; Jenny Prentice; Karl-Heinz Schott; Paul R Wraight
Journal:  J Foot Ankle Res       Date:  2018-01-15       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.